Headlines

Novo Nordisk buys Akero Therapeutics in the US

Published by Global Banking and Finance Review

Posted on October 9, 2025

Featured image for article about Headlines

STOCKHOLM (Reuters) -Danish drugmaker Novo Nordisk said on Thursday it had agreed to buy United States based Akero Therapeutics, a clinical-stage company developing innovative treatments for patients with serious metabolic diseases marked by a high unmet medical need.

(Reporting by Anna Ringstrom, editing by Essi Lehto)

;